Search results for "LIVER DISEASES"

showing 3 items of 223 documents

[Non-operative diagnostic laparoscopy -- pro].

2004

medicine.medical_specialtymedicine.diagnostic_testbusiness.industryGeneral surgeryBiopsyLiver DiseasesDiagnostic laparoscopyGeneral MedicineLiverRisk FactorsBiopsyOutpatientsMedicineHumansLaparoscopybusinessLaparoscopyGastrointestinal NeoplasmsUltrasonographyDeutsche medizinische Wochenschrift (1946)
researchProduct

Focal liver lesions hyperintense on T1-weighted magnetic resonance images.

2009

This article reviews focal liver lesions hyperintense on T1-weighted magnetic resonance (MR) images and describes the underlying etiologies associated with their T1 signal intensity. Although focal liver lesions are commonly detected because of their iso- or hypointensity on T1-weighted images, lesions (benign or malignant) may present with T1 hyperintensity when they contain T1 shortening elements--such as fat, hemorrhage, copper, melanin, and highly concentrated proteins. Our discussion includes the description of state-of-the-art T1-weighted MR sequences and the imaging features of lesions on pre- and postcontrast MR images that are characteristic for lesion composition and useful for ma…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industryLiver DiseasesContrast MediaMagnetic resonance imagingMagnetic Resonance ImagingHyperintensityLesionDiagnosis DifferentialImaging Three-DimensionalmedicineT1 weightedHumansRadiology Nuclear Medicine and imagingRadiologySignal intensityMr imagesmedicine.symptombusinessNuclear medicineSeminars in ultrasound, CT, and MR
researchProduct

Clinical pharmacokinetics of atenolol — A review

1982

Atenolol is a hydrophilic betareceptor blocking drug, which is predominantly eliminated via the kidneys, only about 5% of the atenolol is metabolised by the liver. After oral administration atenolol is incompletely absorbed from the intestine, so about 50% of the beta blocker are finally biovailable. In plasma only 3% of atenolol are protein-bound. There exists a linear relationship between the atenolol plasma levels and the degree of beta blocking effect measured by inhibition of the exercise-induced tachycardia. No correlation was found between plasma levels of atenolol and blood pressure lowering activity of the drug. After oral administration elimination half life of atenolol is calcula…

medicine.medical_specialtymedicine.drug_classAdministration OralBiological AvailabilityRenal functionPharmacologyKidneyIntestinal absorptionPropanolaminesPharmacokineticsRenal DialysisOral administrationInternal medicinemedicineHumansDrug InteractionsPharmacology (medical)cardiovascular diseasesBeta blockerPharmacologyChemistryLiver DiseasesKidney metabolismAtenololKineticsEndocrinologyAtenololIntestinal AbsorptionInjections IntravenousKidney DiseasesBiological half-lifecirculatory and respiratory physiologymedicine.drugEuropean Journal of Drug Metabolism and Pharmacokinetics
researchProduct